title: Psychiatric disorders in a patient with persistent developmental stuttering.
abstract: Persistent developmental stuttering (PDS) is a common disorder of speech with no identifiable cause. Psychiatric disorders appear to be related and influence clinical manifestation of PDS. In this case report, we present the clinical evolution of 1 PDS patient submitted to pharmacological treatment with fluoxetine and speech therapy intervention. At the end of 12 weeks of treatment, she evolved from 28 at Beck Depression Inventory; 32 in the Hamilton Scale for Anxiety; 43 and 47, respectively, in the anxiety and avoidance components of the Liebowitz Social Anxiety Scale; and severe speech impairment according Iowa Scale, to 12 at Beck Depression Inventory; 8 at Hamilton Scale for Anxiety; 25 and 21 at Liebowitz Social Anxiety Scale anxiety and avoidance components, respectively; and moderate speech impairment. Diagnosing and treating psychiatric symptoms in addition to speech therapy appears to be the best therapeutic approach.
authors.affiliation: Neuropsychiatric Branch, Neurology Unit, University Hospital, Federal University of Minas Gerais, Belo Horizonte, Brazil. fernandomvdias@hotmail.com
authors.forename: Fernando Machado Vilhena
authors.initials: FM
authors.lastname: Dias
authors.forename: Patrícia Matos
authors.initials: PM
authors.lastname: Pereira
authors.forename: Flavia Costa de Proença
authors.initials: FC
authors.lastname: Doyle
authors.forename: Antônio Lúcio
authors.initials: AL
authors.lastname: Teixeira
mesh_terms: D001008:Anxiety Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy; D003131:Combined Modality Therapy; D003866:Depressive Disorder; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000523:psychology* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013070:Speech Therapy; D013342:Stuttering / Q000150:complications / Q000523:psychology* / Q000628:therapy; D055815:Young Adult
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors